Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments

被引：0
作者：
G. Grani
D. Tumino
V. Ramundo
L. Ciotti
C. Lomonaco
M. Armillotta
R. Falcone
P. Lucia
M. Maranghi
S. Filetti
C. Durante
机构：
[1] Sapienza University of Rome,Department of Translational and Precision Medicine
[2] University of Catania,Endocrinology, Department of Clinical and Experimental Medicine, Garibaldi
来源：
Journal of Endocrinological Investigation | 2019年 / 42卷
关键词：
Thyroid cancer; TSH variability; Levothyroxine dose adjustment; Real life; Hypothyroidism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1485 / 1490
页数：5
相关论文
共 50 条
  • [21] Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis
    Virili, Camilla
    Giovanella, Luca
    Fallahi, Poupak
    Antonelli, Alessandro
    Santaguida, Maria Giulia
    Centanni, Marco
    Trimboli, Pierpaolo
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [22] A meta-analysis of the value of serum TSH concentration in the diagnosis of differentiated thyroid cancer in patients with thyroid nodules
    Fan, Xiao-Yu
    You, Wei
    Chen, Yao
    Nie, Chen-Cong
    Wang, Xue-Lian
    Lei, Cheng
    Song, Juan
    Luo, Huai-Li
    HELIYON, 2024, 10 (02)
  • [23] Surveillance of TSH-suppressive levothyroxine treatment in thyroid cancer patients:: TRH testing versus basal TSH determination by a third generation assay
    Görges, R
    Saller, B
    Eising, EG
    Quadbeck, B
    Mann, K
    Bockisch, A
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2002, 110 (07) : 355 - 360
  • [24] Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk Thyroid Cancer Patients
    Biondi, Bernadette
    Pucci, Martina
    Pontieri, Gilda
    Formisano, Pietro
    Esposito, Roberta
    THYROID, 2023, 33 (12) : 1402 - 1413
  • [25] Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer
    An, Jee Hyun
    Song, Kee-Ho
    Kim, Dong-Lim
    Kim, Suk Kyeong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2017, 45 (01) : 38 - 50
  • [26] Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
    Ha, Jeonghoon
    Kim, Min Hee
    Jo, Kwanhoon
    Lim, Yejee
    Bae, Ja Seong
    Lee, Sohee
    Kang, Moo Il
    Cha, Bong Yun
    Lim, Dong Jun
    MEDICINE, 2017, 96 (29)
  • [27] Age influences TSH serum levels after withdrawal of 1-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer
    Montesano, Teresa
    Durante, Cosimo
    Attard, Marco
    Crocetti, Umberto
    Meningolo, Domenico
    Bruno, Rocco
    Tumino, Salvatore
    Rubello, Domenico
    Al-Nahhas, Adil
    Colandlea, Marzia
    Maranghi, Marianna
    TravasCio, Laura
    Ronga, Giuseppe
    Torlontano, Massimo
    BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (08) : 468 - 471
  • [28] Patients with differentiated thyroid cancer have a venous gradient in thyroglobulin levels
    Kebebew, Electron
    Reiff, Emily
    CANCER, 2007, 109 (06) : 1078 - 1081
  • [29] The changes of serum copper levels during thyroid cancer
    Kosova, Funda
    Cetin, Bahadir
    Akin, Melih
    Aslan, Sabahattin
    Ari, Zeki
    Cetin, Abdullah
    CLINICAL BIOCHEMISTRY, 2009, 42 (4-5) : 344 - 344
  • [30] Effects of thyroid hormone withdrawal on natriuretic peptides during radioactive iodine therapy in female patients with differentiated thyroid cancer
    Stanciu, Adina Elena
    Hurduc, Anca Elena
    Stanciu, Marcel Marian
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 (08) : 626 - 631
12345